Creatd, Inc.

Creatd, Inc. announced the mutual termination of its letter of intent (LOI) to acquire the remaining equity of C2 Live. The transaction, which was expected to close by October 31, 2026, will not be consummated. Creatd incurred no early termination penalties. The company retains its existing 968,361 shares of C2 Live common stock. Creatd will continue to focus on its strategic priorities, including uplisting to a national exchange and strengthening its balance sheet.

Creatd, Inc. reported a significant divestment and widening net loss for the six months ended June 30, 2026. The company sold its 80.02% equity interest in Fly Flyte, Inc. for $11.6 million. Concurrently, Creatd repurchased shares in Vocal, Inc. and OG Collection, Inc., increasing its ownership in both to 51% and restoring them as majority-owned subsidiaries. The net loss attributable to Creatd, Inc. common stockholders widened to $(17.3) million, compared to $(4.7) million in the prior year.

Creatd, Inc. filed an S-1 registration statement for the resale of up to 180,030 shares of common stock by selling stockholders, from which the company will not receive direct proceeds. A significant recent development is the sale of its 80.02% equity interest in Fly Flyte, Inc. to Catheter Precision, Inc. for $11,554,827 in cash and preferred stock on March 8, 2026. The company also completed an uplist financing in November 2025, raising funds through convertible notes and warrants, though remaining tranches were released after the Flyte divestment. Creatd has undergone multiple reverse stock splits, including a 1-for-20 split in February 2026 and a 1-for-500 split in January 2024, and reported a net loss of $9.4 million for the year ended December 31, 2025, with ongoing going concern doubts.

Creatd, Inc. sold its entire 80.02% equity interest in Fly Flyte, Inc. to Catheter Precision, Inc. for $11.55 million, consisting of $5.78 million in cash and $5.78 million in VTAK Preferred Series D Stock. The company also filed an S-1 registration statement for the resale of up to 180,030 shares of common stock by selling stockholders, from which Creatd will not receive direct proceeds. Additionally, Creatd detailed recent financing activities, including partially funded tranches of a $7.78 million convertible note and warrant offering, with remaining obligations released following the Fly Flyte sale. The company reported a net loss of $9.4 million for the year ended December 31, 2025, and faces a going concern warning.

Creatd, Inc. filed an S-1 registration statement for the resale of up to 180,030 shares of common stock by selling stockholders, from which the company will not receive direct proceeds. This filing comes as the company recently divested its entire 80.02% equity interest in Fly Flyte, Inc. for $11.55 million in cash and preferred stock. Despite these strategic moves, the company reported a $9.4 million net loss for 2025 and faces substantial doubt about its ability to continue as a going concern, as highlighted in its financial statements.